IL10 and dengue disease: With respect to a possible pathogenic role for aberrant IL-10 production in DHF/DSS patients, targeting the Syk/PKA/PI3K/PKB/GSK-3β/CREB signaling axis may represent a viable therapeutic strategy for combating the progression of severe dengue diseases.